Demecarium Bromide

地美溴铵

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDemecarium Bromide
Drug Alias Name地美溴胺bromuro de demecario地美卡林demecarii bromidum溴化癸二胺苯酯 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcetylcholinesterase inhibitors
TargetsAcetylcholinesterase
Therapy Area/IndicationsGlaucoma
Global Approved IndicationsGlaucoma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1959/08/05
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsGlaucoma

Other Information

ATC CodeS01EB04
Related LinksWikipediaDrugBankKEGG